Business updates11 Sep 2026 · 8:50 AM IST
GLENMARKGlenmark Pharmaceuticals
Launches Ryaltris in Brazil
The launch expands the company's respiratory business outside India.
Price, Thursday's close₹2,415.00▼ 0.82%
Last 5 days
What happened
- Glenmark Pharmaceuticals launched Ryaltris in Brazil, expanding its global respiratory portfolio.
Read the source
This is a summary of public news about Glenmark Pharmaceuticals, for information only. It is not a recommendation to buy, sell or hold GLENMARK.
Glenmark Pharmaceuticals in the news before
- 23 SEP 2026 · REGULATORYUS FDA closes its Goa plant inspection with a VAI classification